Armata Pharmaceuticals (ARMP) Change in Accured Expenses (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Change in Accured Expenses of -$352000.0 for Q1 2026, up 36.35% on a YoY basis from -$258164.5 in Q1 2025, and down 201.15% sequentially from $348000.0 in Q4 2025.
Armata Pharmaceuticals (ARMP) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 14 years of Change in Accured Expenses data on file, last reported at -$352000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 36.35% year-over-year to -$352000.0; the trailing twelve-month figure through Mar 2026 stood at $112000.0 (up 103.97% YoY), and the FY2025 full-year result was -$89000.0, up 97.63% from the prior year.
- Change in Accured Expenses fell to -$352000.0 in Q1 2026, from $348000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.5 million in Q2 2023 to a low of -$1.7 million in Q4 2024.
- A 5-year average of -$262529.4 and a median of -$265000.0 in 2025 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses jumped 331.06% in 2022 and sank 4330.43% in 2023, its largest moves.
- Tracing ARMP's Change in Accured Expenses over 5 years: stood at $23000.0 in 2022, then slumped by 4330.43% to -$973000.0 in 2023, then plunged by 77.18% to -$1.7 million in 2024, then jumped by 120.19% to $348000.0 in 2025, then plunged by 201.15% to -$352000.0 in 2026.
- Business Quant data shows ARMP's Change in Accured Expenses at -$352000.0 in Q1 2026, $348000.0 in Q4 2025, and $381000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | -16.74 Mn |
| 10 | Armata Pharmaceuticals | 168.22 Mn | 163.42 Mn | - | -352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -352,000.00 |
| Mar 31, 2026 | -352,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Sep 30, 2025 | 381,000.00 |
| Sep 30, 2025 | 381,000.00 |
| Jun 30, 2025 | -265,000.00 |
| Jun 30, 2025 | -265,000.00 |
| Mar 31, 2025 | -553,000.00 |
| Mar 31, 2025 | -553,000.00 |
| Dec 31, 2024 | -1.72 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Sep 30, 2024 | 111,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | -654,000.00 |
| Jun 30, 2024 | -654,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Mar 31, 2024 | -1.49 Mn |
| Dec 31, 2023 | -973,000.00 |
| Dec 31, 2023 | -973,000.00 |